title: [Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases].
authors.forename: Lucinda
authors.initials: L
authors.lastname: Sánchez-Eslava
authors.forename: Hèctor
authors.initials: H
authors.lastname: Corominas
authors.forename: Manel
authors.initials: M
authors.lastname: Riera
authors.forename: Ramon
authors.initials: R
authors.lastname: Fíguls
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000451:nursing; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000451:nursing; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D057240:Patient Preference; D012646:Self Administration; D011795:Surveys and Questionnaires
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab